Forwardlooking statements are generally identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans” and similar expressions.
We will not send you any unsolicited materials. Backed by a worldclass R&D organisation, sanofiaventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. Please note that this form is not to be used to report health concerns, adverse event notifications or to ask technical or medical questions regarding Sanofi products. Around the world, more than 100,000 people at Sanofi are dedicated to making a difference in patients' daily lives, wherever they live, and enabling them to enjoy a healthier life.
Every day, the company invests more than EUR1 million in research and development.
Copyright © 2016-2019 Sanofi. Former Shareholder Information Company Name: Protein Sciences Corporation, a Sanofi company Corporate Headquarters: U.S. Headquarters Discovery Drive Swiftwater, PA 18370 Other Locations: 875 Research Parkway, Meriden CT 06450 USA Your email and its content will be used to provide you with an answer to your message. Customer Service 1-800-268-4171. Sanofi pasteur will contribute approximately $ 25 million to the overall project.
Vaccine Information Service 416-667-2779 1-888-621-1146 Sanofi Pasteur vaccines. Pentru a ne contacta, vă rugăm să folosiți formularul de mai jos.Vă informăm că acest formular nu este destinat raportării de reacţii adverse la produsele Sanofi.
Vă informăm că acest formular nu este destinat raportării de reacţii adverse la produsele Sanofi. In an attempt to minimize the impact of a pandemic, many countries are developing national and transnational plans against an eventual influenza pandemic situation.Sanofi pasteur, the vaccines division of the sanofiaventis Group, is committed to global pandemic preparedness.
You have the possibility to access, to modify, to rectify and … Pentru solicitarea de informații medicale, raportarea de evenimente adverse și/ sau reclamații de calitate, te rugăm să apelezi serviciul call center 24/ 7, telefon (+40) 021 317 31 36, sau să ne contactezi prin email la adresele: According to the World Health Organization (WHO), the next pandemic is likely to result in 1 to 2.3 million hospitalizations and 280,000 to 650,000 deaths in industrialized nations alone.
A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The retrofit will begin when the company’s new influenza vaccine manufacturing facility is licensed by the FDA and operational. Acest website folosește cookie-uri pentru urmărirea traficului și îmbunătățirea conținutului. The API is used by other pharmas here … © 2005-2020 sanofi-aventis U.S. LLC - All rights reserved Contact. Consumer Healthcare will become a standalone business unit.
vaccine, sanofi pasteur is actively involved in projects in the U.S. and Europe, with the goal of developing a vaccine to protect against a pandemic influenza virus.
Contact Us. Sanofi pasteur is the largest company entirely dedicated to vaccines.
Swiftwater, Pa., and Lyon (France) – 14 June, 2007 – Sanofi pasteur, the vaccines division of the sanofiaventis Group, today announced it has been awarded a $ 77.4 million contract by the United States Department of Health and Human Services (HHS) to retrofit its existing influenza vaccine manufacturing facility. Puteţi de asemenea să raportaţi reacţii adverse la produsele Sanofi către Agenția Națională a Medicamentului și a Dispozitivelor Medicale (ANMDM); pentru detalii referitoare la raportarea de reacţii adverse, vizitați site-ul Vă mulțumim pentru interesul acordat companiei Sanofi. Other than as required by applicable law, sanofiaventis does not undertake any obligation to update or revise any forwardlooking information or statements.Sanofi Pasteur Awarded Contract to Retrofit Influenza Vaccine FacilitySanofi pasteur continues to join with the U.S. government in enhancing the nation’s pandemic preparedness to protect public health
Swiftwater, Pa., and Lyon (France) – 14 June, 2007 – Sanofi pasteur, the vaccines division of the sanofiaventis Group, today announced it has been awarded a $ 77.4 million contract by the United States Department of Health and Human Services (HHS) to retrofit its existing influenza vaccine manufacturing facility.